Literature DB >> 30413544

Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries.

Jillian L Peters1, Wesley M Durand2, Kristina A Monteiro2, Luba Dumenco2, Paul George2.   

Abstract

INTRODUCTION: As the opioid epidemic progresses, a better understanding of those at elevated risk of opioid overdose is needed, particularly for populations whose growing risk may be overlooked. Medicare recipients under age 65 (Medicare-disability beneficiaries [MDBs]) are one such population. We sought to analyze characteristics of opioid-overdose hospitalizations among MDBs and quantify the contribution of this population to opioid-overdose hospitalizations overall.
METHODS: This retrospective cohort study included patients hospitalized for opioid overdose in the National/Nationwide Inpatient Sample from 1998 to 2013. The primary outcome measurements were number and characteristics of discharges, including patient sex, age, race, prescription opioid versus heroin overdose, and comorbidities.
RESULTS: MDBs constituted 11.7% of US opioid overdose hospitalizations among those under 65 years of age in 1998; this proportion grew to 24.5% by 2013 (P < .0001). The proportion of female patients grew markedly among this cohort (P < .0001) and were disproportionately represented among MDBs (P < .0001). Prescription opioid overdose accounted for a larger proportion of opioid overdose hospitalizations among MDBs than among non-Medicare-insured patients under 65 years old (P < .0001). MDBs generally exhibited greater comorbidity burden versus non-Medicare-insured patients under age 65; however, chronic drug and alcohol abuse were less commonly documented among the Medicare cohort (P < .0001).
CONCLUSIONS: MDBs constitute a substantial and growing proportion of opioid overdose hospitalizations in the United. To prevent opioid overdoses among MDBs, care must be taken to address the unique needs of this population. © Copyright 2018 by the American Board of Family Medicine.

Entities:  

Keywords:  Drug Overdose; Hospitalization; Inpatients; Medicare; Opioid Analgesics; Retrospective Studies

Mesh:

Substances:

Year:  2018        PMID: 30413544     DOI: 10.3122/jabfm.2018.06.180152

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  5 in total

1.  Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: Differences by insurance status.

Authors:  Vítor Soares Tardelli; Thiago Marques Fidalgo; Julian Santaella; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2019-09-21       Impact factor: 4.492

2.  Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation.

Authors:  Victor Liaw; Yong-Fang Kuo; Mukaila A Raji; Jacques Baillargeon
Journal:  Public Health Rep       Date:  2020-01       Impact factor: 2.792

3.  Association of Disability With Mortality From Opioid Overdose Among US Medicare Adults.

Authors:  Yong-Fang Kuo; Mukaila A Raji; James S Goodwin
Journal:  JAMA Netw Open       Date:  2019-11-01

Review 4.  Cost-effectiveness and Safety of Interspinous Process Decompression (Superion).

Authors:  Kevin Cairns; Tim Deer; Dawood Sayed; Kim van Noort; Kevin Liang
Journal:  Pain Med       Date:  2019-12-01       Impact factor: 3.750

5.  A Vulnerability Assessment for a Future HIV Outbreak Associated With Injection Drug Use in Illinois, 2017-2018.

Authors:  Cara Jane Bergo; Jennifer R Epstein; Stacey Hoferka; Marynia Aniela Kolak; Mai T Pho
Journal:  Front Sociol       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.